ERBB2 and breast carcinoma: Surface-enhanced Raman spectroscopy (SERS)-vertical flow assays have shown promise for the multiplex detection of exosome proteins (Mucin short variant S1 (MUC1), HER2, and CEA) which are useful for identifying breast cancer subtypes.